Mapping drug-target interactions and synergy in multi-molecular therapeutics for pressure-overload cardiac hypertrophy
Abstract Advancements in systems biology have resulted in the development of network pharmacology, leading to a paradigm shift from “one-target, one-drug” to “target-network, multi-component therapeutics”. We employ a chimeric approach involving in-vivo assays, gene expression analysis, cheminformat...
Guardado en:
Autores principales: | Aparna Rai, Vikas Kumar, Gaurav Jerath, C. C. Kartha, Vibin Ramakrishnan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f53b632952146e7b40af56c91c87711 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Three TF Co-expression Modules Regulate Pressure-Overload Cardiac Hypertrophy in Male Mice
por: Yao-Ming Chang, et al.
Publicado: (2017) -
Inhibition of GTPase Rac1 expression by vitamin D mitigates pressure overload-induced cardiac hypertrophy
por: Ali Moradi, et al.
Publicado: (2021) -
A Peptide-Functionalized Magnetic Nanoplatform-Loaded Melatonin for Targeted Amelioration of Fibrosis in Pressure Overload-Induced Cardiac Hypertrophy
por: Zhao X, et al.
Publicado: (2020) -
Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling.
por: Sara Vandenwijngaert, et al.
Publicado: (2013) -
Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
por: Nan Zhang, et al.
Publicado: (2021)